vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.

ASCENT INDUSTRIES CO. is the larger business by last-quarter revenue ($11.9M vs $7.8M, roughly 1.5× CRYO CELL INTERNATIONAL INC). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -48.7%, a 39.9% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-196.0K). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -34.9%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

ACNT vs CCEL — Head-to-Head

Bigger by revenue
ACNT
ACNT
1.5× larger
ACNT
$11.9M
$7.8M
CCEL
Growing faster (revenue YoY)
ACNT
ACNT
+15.6% gap
ACNT
13.3%
-2.3%
CCEL
Higher net margin
ACNT
ACNT
39.9% more per $
ACNT
-8.8%
-48.7%
CCEL
More free cash flow
CCEL
CCEL
$1.4M more FCF
CCEL
$1.2M
$-196.0K
ACNT
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-34.9%
ACNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNT
ACNT
CCEL
CCEL
Revenue
$11.9M
$7.8M
Net Profit
$-1.0M
$-3.8M
Gross Margin
14.6%
77.9%
Operating Margin
-21.0%
-50.6%
Net Margin
-8.8%
-48.7%
Revenue YoY
13.3%
-2.3%
Net Profit YoY
-1.2%
-105.1%
EPS (diluted)
$-0.11
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
CCEL
CCEL
Q4 25
$11.9M
$7.8M
Q3 25
$19.7M
$7.8M
Q2 25
$18.7M
$7.9M
Q1 25
$24.7M
$8.0M
Q4 24
$10.5M
$8.0M
Q3 24
$20.9M
$8.1M
Q2 24
$21.5M
$8.0M
Q1 24
$28.0M
$7.9M
Net Profit
ACNT
ACNT
CCEL
CCEL
Q4 25
$-1.0M
$-3.8M
Q3 25
$-2.1M
$749.4K
Q2 25
$6.3M
$355.8K
Q1 25
$-2.3M
$282.9K
Q4 24
$-1.0M
$-1.9M
Q3 24
$-6.2M
$1.1M
Q2 24
$-926.0K
$655.8K
Q1 24
$-5.5M
$556.2K
Gross Margin
ACNT
ACNT
CCEL
CCEL
Q4 25
14.6%
77.9%
Q3 25
29.7%
77.0%
Q2 25
26.1%
76.6%
Q1 25
19.3%
75.1%
Q4 24
24.3%
78.4%
Q3 24
14.4%
73.6%
Q2 24
13.1%
74.8%
Q1 24
8.3%
73.7%
Operating Margin
ACNT
ACNT
CCEL
CCEL
Q4 25
-21.0%
-50.6%
Q3 25
-4.1%
24.3%
Q2 25
-14.4%
18.8%
Q1 25
-4.2%
13.3%
Q4 24
-25.4%
-1.5%
Q3 24
-9.4%
17.2%
Q2 24
-8.6%
17.3%
Q1 24
-15.5%
10.5%
Net Margin
ACNT
ACNT
CCEL
CCEL
Q4 25
-8.8%
-48.7%
Q3 25
-10.6%
9.6%
Q2 25
33.7%
4.5%
Q1 25
-9.3%
3.5%
Q4 24
-9.8%
-23.2%
Q3 24
-29.5%
13.0%
Q2 24
-4.3%
8.2%
Q1 24
-19.7%
7.1%
EPS (diluted)
ACNT
ACNT
CCEL
CCEL
Q4 25
$-0.11
$-0.46
Q3 25
$-0.22
$0.09
Q2 25
$0.65
$0.04
Q1 25
$-0.23
$0.03
Q4 24
$-0.11
$-0.23
Q3 24
$-0.61
$0.13
Q2 24
$-0.09
$0.08
Q1 24
$-0.54
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
CCEL
CCEL
Cash + ST InvestmentsLiquidity on hand
$57.6M
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$87.0M
$-18.6M
Total Assets
$111.9M
$61.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
CCEL
CCEL
Q4 25
$57.6M
$3.3M
Q3 25
$58.0M
$3.2M
Q2 25
$60.5M
$4.4M
Q1 25
$14.3M
$3.5M
Q4 24
$16.1M
$3.5M
Q3 24
$8.5M
$2.1M
Q2 24
$3.6M
$1.5M
Q1 24
$1.3M
$979.6K
Total Debt
ACNT
ACNT
CCEL
CCEL
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$0
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
ACNT
ACNT
CCEL
CCEL
Q4 25
$87.0M
$-18.6M
Q3 25
$87.1M
$-14.8M
Q2 25
$89.7M
$-15.6M
Q1 25
$91.2M
$-14.7M
Q4 24
$93.5M
$-13.2M
Q3 24
$94.7M
$-9.6M
Q2 24
$101.0M
$-10.7M
Q1 24
$102.0M
$-10.3M
Total Assets
ACNT
ACNT
CCEL
CCEL
Q4 25
$111.9M
$61.7M
Q3 25
$119.9M
$63.2M
Q2 25
$122.6M
$64.4M
Q1 25
$152.5M
$64.4M
Q4 24
$147.3M
$64.7M
Q3 24
$148.6M
$62.9M
Q2 24
$158.2M
$62.6M
Q1 24
$161.0M
$61.7M
Debt / Equity
ACNT
ACNT
CCEL
CCEL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
CCEL
CCEL
Operating Cash FlowLast quarter
$266.0K
$1.3M
Free Cash FlowOCF − Capex
$-196.0K
$1.2M
FCF MarginFCF / Revenue
-1.7%
15.5%
Capex IntensityCapex / Revenue
3.9%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
CCEL
CCEL
Q4 25
$266.0K
$1.3M
Q3 25
$1.3M
$2.5M
Q2 25
$-1.4M
$707.0K
Q1 25
$-700.0K
$954.1K
Q4 24
$8.8M
$2.2M
Q3 24
$3.4M
$2.4M
Q2 24
$2.2M
$1.8M
Q1 24
$263.0K
$-356.9K
Free Cash Flow
ACNT
ACNT
CCEL
CCEL
Q4 25
$-196.0K
$1.2M
Q3 25
$695.0K
$2.5M
Q2 25
$-1.5M
$644.6K
Q1 25
$-1.0M
$892.0K
Q4 24
$8.4M
$2.1M
Q3 24
$3.1M
$2.3M
Q2 24
$1.9M
$21.5K
Q1 24
$25.0K
$-814.6K
FCF Margin
ACNT
ACNT
CCEL
CCEL
Q4 25
-1.7%
15.5%
Q3 25
3.5%
31.9%
Q2 25
-8.3%
8.1%
Q1 25
-4.1%
11.2%
Q4 24
80.6%
26.8%
Q3 24
15.1%
27.9%
Q2 24
9.1%
0.3%
Q1 24
0.1%
-10.4%
Capex Intensity
ACNT
ACNT
CCEL
CCEL
Q4 25
3.9%
0.9%
Q3 25
3.1%
0.5%
Q2 25
0.8%
0.8%
Q1 25
1.3%
0.8%
Q4 24
3.7%
0.1%
Q3 24
1.3%
2.3%
Q2 24
1.0%
21.8%
Q1 24
0.9%
5.8%
Cash Conversion
ACNT
ACNT
CCEL
CCEL
Q4 25
Q3 25
3.38×
Q2 25
-0.22×
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

CCEL
CCEL

Segment breakdown not available.

Related Comparisons